What question did this study set out to answer?

The research aims to explore the role of TFAP2A in regulating SGPP2 and its effects on lipid metabolism and tumor progression in lung adenocarcinoma.

TFAP2A regulates SGPP2 transcription to promote lipid accumulation and activate the Wnt/β-catenin signaling pathway to promote malignant progression in lung adenocarcinoma

View Full Paper

Ask AI

Bookmark

Authors

Demonstrates that TFAP2A regulates SGPP2 to enhance lipid accumulation in lung adenocarcinoma, suggesting new therapeutic targets.

The research aims to explore the role of TFAP2A in regulating SGPP2 and its effects on lipid metabolism and tumor progression in lung adenocarcinoma.
Conducted bioinformatics analysis to assess SGPP2 and TFAP2A expression patterns.
Employed qRT-PCR, western blotting, and IHC for mRNA and protein expression measurement.
Used various assays (CCK-8, EdU, transwell, and wound-healing) to evaluate cellular proliferation, migration, and lipid metabolism.
Performed ChIP and dual-luciferase reporter assays to investigate the regulatory relationship between TFAP2A and SGPP2.
Examined in vivo tumorigenic potential in a nude mouse xenograft model.
Both SGPP2 and TFAP2A were found to be upregulated in lung adenocarcinoma.
High SGPP2 levels correlated with lymph node metastasis.
SGPP2 promoted proliferation, migration, and EMT in LUAD cells.
TFAP2A directly activated SGPP2 expression, while SGPP2 inhibited TFAP2A expression.
SGPP2 overexpression increased S1P levels, leading to enhanced lipid accumulation and activation of the Wnt/β-catenin pathway.

Li et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark